Intrinsic Value of S&P & Nasdaq Contact Us

CorMedix Inc. CRMD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
82/100
5/7 Pass
SharesGrow Intrinsic Value
$31.96
+337.8%
Analyst Price Target
$13.75
+88.4%

Stock Statistics — CRMD

CorMedix Inc. (CRMD) has a market capitalization of $577.07M and trades at $7.30. The 52-week range is 5.6-17.43.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 3.2, Earnings Per Share (EPS) of $2.25, annual revenue of $311.71M.

The stock has a beta of 1.41, operates in the Healthcare sector.

Trading Data
Current Price$7.30
52-Week Range5.6-17.43
Volume1.16M
Avg Volume (30D)1.73M
Market Cap$577.07M
Beta (1Y)1.41
Company
IPO Date2010-05-13
Employees64
CEOJoseph Todisco
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS21900C3088
CUSIP21900C308
Income (Latest Year)
Revenue$311.71M
Gross Profit$275.75M
EBITDA$165.13M
Operating Income$150.14M
Net Income$163.06M
EPS$2.25
EPS Diluted$2.04
Shares Outstanding$72.03M
Balance Sheet (Latest Year)
Total Assets$826.14M
Current Assets$350.47M
Cash & ST Investments$149.52M
Total Liabilities$420.84M
Total Debt$148.91M
Net Debt$3.09M
Total Equity$405.31M
Debt / Equity0.37
Valuation Ratios
P/E Ratio3.2
P/S Ratio1.85
P/B Ratio1.42
EV/EBITDA (approx)3.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message